4 completed, 1 unknown. 3 Phase 3, 1 Early Phase 1, 1 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 3 |
| Early Phase 1 | 1 | Unknown 1 |
| Phase 2 | 1 | Completed 1 |
| Phase 4 | 1 | Completed 1 |
Follow sofosbuvir and daclatasvir: new trials by email Literature Review of sofosbuvir and daclatasvir trials Research Report on sofosbuvir and daclatasvir
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Levels of Interleukin-6 andTransforming Growth Factor Beta in HCV Patients Sera sofosbuvir and daclatasvir - Hepatitis C, Chronic | Early Phase 1 | Unknown | Assiut University | 40 | 2022-10-01 | 2022-07-26 |
| Sofosbuvir and Daclatasvir for Treating Hepatitis C in 200 Patients Co-infected With Human Immunodeficiency Virus sofosbuvir and daclatasvir - Hepatitis C Virus Infection, Response to Therapy of, Human Immunodeficiency Virus | Phase 3 | Completed | Tehran University of Medical Sciences | 232 | 2017-01-01 | 2019-02-20 |
| Sofosbuvir and Daclatasvir in Treating Hepatitis C, A Study on 1000 Patients sofosbuvir and daclatasvir - Hepatitis C | Phase 4 | Completed | Tehran University of Medical Sciences | 1448 | 2016-09-01 | 2019-02-15 |
| Sofosbuvir Containing Regimens for the Treatment of Chronic HCV GT3 Infected Patients sofosbuvir and daclatasvir, ledipasvir/sofosbuvir - Chronic Hepatitis C Infection | Phase 3 | Completed | Humanity and Health Research Centre | 48 | 2015-05-01 | 2018-03-19 |
| DAAs Treatment for Chronic HCV/HBV Co-infection Patients(DASCO) Ledipasvir/Sofosbuvir, Sofosbuvir and Daclatasvir, Ombitasvir, Paritaprevir, Ritonavir, Dasabuvir - Chronic Hepatitis C Infection, HBV Coinfection | Phase 2 / Phase 3 | Completed | Humanity and Health Research Centre | 23 | 2015-02-01 | 2021-09-01 |
Hepatitis C (2) · Acquired Immunodeficiency Syndrome (1) · Camurati-Engelmann Syndrome (1) · Hepatitis C, Chronic (1)
Humanity and Health Research Centre (2) · Tehran University of Medical Sciences (2) · Assiut University (1)
China (2) · Iran (2) · Egypt (1)
George Lau, M.D. (1) · George Lau, MD (1) · Reza Malekzadeh (1) · Reza Malekzadeh, MD (1)